The TCGA KIRC database and IHC results showed that NFE2L3 was highly expressed in ccRCC tissues (Fig. 6a; Supplementary Fig. S2k), and its high expression was associated with a poor prognosis in ccRCC patients (Fig. 6b). Here, NFE2L3 is linked to nonpapillary renal cell carcinoma.